Marico Limited Q1 FY27 Results

Marico's consolidated revenue grew 23% to ₹3,957 crore for the quarter ended June 30, 2026, up from ₹3,221 crore in the same period last year. Consolidated net profit increased by 27% to ₹652 crore, from ₹513 crore year-on-year.

Reader Takeaway: Strong double-digit growth in revenue and profit; strategic international expansion and brand integration.

What just happened

Marico Limited announced its first-quarter financial results for the fiscal year 2027. The company posted a consolidated revenue of ₹3,957 crore, marking a significant 23% increase compared to ₹3,221 crore in the corresponding quarter of the previous year. Net profit also saw a substantial jump of 27%, reaching ₹652 crore from ₹513 crore.

The India segment generated ₹3,003 crore in revenue with a segment result of ₹580 crore. The international business contributed ₹954 crore in revenue and ₹257 crore in segment result.

Why this matters

This robust performance indicates Marico's expanding market reach and effective business strategies. The significant growth in both revenue and profit is a positive signal for shareholders, demonstrating the company's ability to drive top-line and bottom-line expansion amidst evolving market dynamics.

The backstory

Marico has recently completed the integration of its digital-first brands, Just Herbs (effective October 1, 2025) and Beardo (effective June 29, 2026), through voluntary liquidation of their respective entities. These undertakings have now been distributed to Marico Limited, simplifying its business structure.

Furthermore, Marico South East Asia Corporation acquired a 75% stake in Vietnam-based skincare company Skinetiq Joint Stock Company on April 2, 2026. This strategic move expands Marico's international footprint in the burgeoning skincare market.

What changes now

The integration of Beardo and Just Herbs is expected to streamline operations and unlock synergies. The acquisition of a majority stake in Skinetiq positions Marico for growth in the Southeast Asian skincare sector, particularly in Vietnam.

Risks to watch

Investors should be aware of the accounting reclassification of certain customer-related advertisement and promotional expenses. While Marico states this change has no impact on profit before tax, equity, or EPS, it has been applied retrospectively to revenue figures. This means direct comparison of current revenue with historical data needs careful consideration of this accounting adjustment.

Peer comparison

Marico operates in the Fast-Moving Consumer Goods (FMCG) sector, competing with companies like Hindustan Unilever, Godrej Consumer Products, and Dabur India. While specific peer results for Q1 FY27 are not yet available, Marico's reported growth rates in revenue and profit appear strong, suggesting competitive performance.

Context metrics (time-bound)

• Consolidated Revenue (Q1 FY27): ₹3,957 crore (vs. ₹3,221 crore in Q1 FY26)
• Consolidated Net Profit (Q1 FY27): ₹652 crore (vs. ₹513 crore in Q1 FY26)
• India Revenue (Q1 FY27): ₹3,003 crore
• International Revenue (Q1 FY27): ₹954 crore

What to track next

Investors will be keen to monitor the performance of Marico's integrated brands and the growth trajectory of Skinetiq in Vietnam. Continued progress in these strategic initiatives, alongside overall market performance, will be key factors to watch in upcoming quarters.